GSA Capital Partners’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
Other funds holding IMDZ
PS
AAM
TAL
GF
SAM
BCM
GSA Capital Partners's IMDZ Position: Q1 2019 in Review
GSA Capital Partners sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 41,068 shares — an estimated $53K sold.
GSA Capital Partners first reported a position in IMDZ in Q2 2018 and held it in 3 quarters. The position peaked at $72K in Q3 2018. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.
- GSA Capital Partners reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
- GSA Capital Partners sold 41,068 Immune Design Corp. shares in Q1 2019, an estimated $53K.
- GSA Capital Partners first reported a position in Immune Design Corp. in Q2 2018 and held it in 3 quarters.
- GSA Capital Partners's Immune Design Corp. position peaked at $72K in Q3 2018.
- 68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.